Gustave Roussy Prize 2027: €200,000 International Cancer Research Award Now Accepting Applications Worldwide

Researchers making groundbreaking contributions to the fight against cancer now have the opportunity to gain one of the world’s most prestigious recognitions in oncology. The Gustave Roussy Prize 2027 has officially opened applications, inviting outstanding cancer researchers from across the globe to compete for an award valued at €200,000.

Established by the Fondation Gustave Roussy, with the support of Laboratoires Pierre Fabre as its founding sponsor, the prize recognizes researchers whose scientific discoveries have significantly transformed cancer diagnosis, treatment, prevention, or patient care. Since its launch in 2025, the award has rapidly become one of the most highly respected international distinctions in oncology research, celebrating scientific excellence and innovations that deliver measurable and lasting benefits for cancer patients worldwide.

Application Deadline: August 26, 2026, at 4:00 p.m. CEST

About the Gustave Roussy Prize

Cancer remains one of the world’s leading health challenges, affecting millions of people every year. Continuous scientific research has resulted in remarkable progress in early diagnosis, precision medicine, immunotherapy, targeted therapies, prevention strategies, and patient-centered care. The Gustave Roussy Prize was created to recognize researchers whose discoveries have contributed substantially to these advances.

The award was launched in 2025 to commemorate two important milestones:

• The 150th anniversary of Professor Gustave Roussy’s birth.
• The centenary of the Gustave Roussy Institute.

Professor Gustave Roussy is widely recognized as a pioneer in cancer care. In 1921, he established one of the world’s first medical consultations dedicated specifically to patients with tumors, laying the foundation for modern comprehensive oncology care. Today, Gustave Roussy is recognized as Europe’s leading cancer center and continues to drive innovation through cutting-edge research, education, and patient care.

Prize Value

The Gustave Roussy Prize carries a total value of €200,000, making it one of the largest international awards dedicated to cancer research.

The funding is divided into two components:

1. €100,000 awarded directly to the laureate for unrestricted personal use.
2. €100,000 allocated to support an innovative oncology research project, enabling continued scientific discovery and future breakthroughs.

Purpose of the Award

The prize celebrates scientific breakthroughs that have created tangible improvements in cancer care and patient outcomes.

Research achievements may relate to:

• Cancer diagnosis
• Cancer treatment
• Cancer prevention
• Clinical oncology
• Translational medicine
• Precision medicine
• Immunotherapy
• Biomarker discovery
• Screening technologies
• Therapeutic innovation
• Improved quality of patient care
• Better understanding of cancer biology

The emphasis is not simply on academic achievement but on research that demonstrates measurable clinical impact and has improved the lives of patients.

Who Can Apply?

Applications are welcomed from researchers worldwide regardless of nationality or institutional affiliation.

Eligible candidates include researchers working at:

• Universities
• Cancer research institutes
• Medical schools
• Hospitals
• Public research organizations
• Private research institutions
• International research centers

Applicants are expected to demonstrate exceptional scientific excellence and a research record that has significantly advanced oncology.

Selection Process

Applications will be evaluated by an independent international jury composed of leading experts in oncology and biomedical research.

Selection will be based exclusively on:

• Scientific excellence
• Originality of discoveries
• Clinical impact
• Innovation
• Long-term contribution to oncology
• Demonstrated benefits for patients

Importantly, evaluations are conducted without regard to discipline, institution, or nationality, ensuring a fair and merit-based selection process.

Why This Prize Matters

Receiving the Gustave Roussy Prize represents more than financial recognition. It places recipients among the world’s leading oncology researchers and highlights discoveries that have changed the landscape of cancer care.

The prize also encourages continued innovation by providing dedicated funding for future research projects, ensuring that today’s breakthroughs continue generating tomorrow’s solutions.

With cancer affecting millions globally, supporting transformative research remains essential for improving survival rates, enhancing quality of life, and developing more effective treatments. This award reinforces the importance of scientific collaboration and recognizes researchers whose work creates lasting benefits for humanity.

Previous Laureates

The prize has already honored internationally renowned scientists.

Previous recipients include:

• 2025: Professor Charles Swanton
• 2026: Professor Luis Diaz Jr.

These researchers were recognized for discoveries that have significantly influenced modern oncology and patient treatment.

Award Ceremony

The selected laureate for the 2027 edition will receive the prize on February 4, 2027, during World Cancer Day, highlighting the global importance of cancer research and international collaboration in combating the disease.

How to Apply

Researchers interested in the Gustave Roussy Prize 2027 should complete the official online application before the deadline.

Applicants are encouraged to present their most impactful scientific achievements, clearly demonstrate clinical relevance, and provide evidence showing how their discoveries have advanced cancer diagnosis, treatment, prevention, or patient care.

Application Deadline: August 26, 2026, at 4:00 p.m. CEST.

Interested applicants can find more information through the official Gustave Roussy website

Discover more global awards opportunities on OFY here